Pre-clinical and clinical development of the first placental malaria vaccine

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Pre-clinical and clinical development of the first placental malaria vaccine. / Pehrson, Caroline; Salanti, Ali; Theander, Thor G; Nielsen, Morten A.

In: Expert Review of Vaccines, Vol. 16, No. 6, 2017, p. 613-624.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Pehrson, C, Salanti, A, Theander, TG & Nielsen, MA 2017, 'Pre-clinical and clinical development of the first placental malaria vaccine', Expert Review of Vaccines, vol. 16, no. 6, pp. 613-624. https://doi.org/10.1080/14760584.2017.1322512

APA

Pehrson, C., Salanti, A., Theander, T. G., & Nielsen, M. A. (2017). Pre-clinical and clinical development of the first placental malaria vaccine. Expert Review of Vaccines, 16(6), 613-624. https://doi.org/10.1080/14760584.2017.1322512

Vancouver

Pehrson C, Salanti A, Theander TG, Nielsen MA. Pre-clinical and clinical development of the first placental malaria vaccine. Expert Review of Vaccines. 2017;16(6):613-624. https://doi.org/10.1080/14760584.2017.1322512

Author

Pehrson, Caroline ; Salanti, Ali ; Theander, Thor G ; Nielsen, Morten A. / Pre-clinical and clinical development of the first placental malaria vaccine. In: Expert Review of Vaccines. 2017 ; Vol. 16, No. 6. pp. 613-624.

Bibtex

@article{07a783ed902b4cf1aaeef8908c5d8469,
title = "Pre-clinical and clinical development of the first placental malaria vaccine",
abstract = "Introduction: Malaria during pregnancy is a massive health problem in endemic areas. Placental malaria infections caused by Plasmodium falciparum are responsible for up to one million babies being born with a low birth weight every year. Significant efforts have been invested into preventing the condition. Areas covered: Pub Med was searched using the broad terms 'malaria parasite placenta' to identify studies of interactions between parasite and host, 'prevention of placental malaria' to identify current strategies to prevent placental malaria, and 'placental malaria vaccine' to identify pre-clinical vaccine development. However, all papers from these searches were not systematically included. Expert commentary: The first phase I clinical trials of vaccines are well underway. Trials testing efficacy are more complicated to carry out as only women that are exposed to parasites during pregnancy will contribute to endpoint measurements, further it may require extensive follow-up to establish protection. Future second generation vaccines may overcome the inherent challenges in making an effective placental malaria vaccine.",
author = "Caroline Pehrson and Ali Salanti and Theander, {Thor G} and Nielsen, {Morten A}",
year = "2017",
doi = "10.1080/14760584.2017.1322512",
language = "English",
volume = "16",
pages = "613--624",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Taylor & Francis",
number = "6",

}

RIS

TY - JOUR

T1 - Pre-clinical and clinical development of the first placental malaria vaccine

AU - Pehrson, Caroline

AU - Salanti, Ali

AU - Theander, Thor G

AU - Nielsen, Morten A

PY - 2017

Y1 - 2017

N2 - Introduction: Malaria during pregnancy is a massive health problem in endemic areas. Placental malaria infections caused by Plasmodium falciparum are responsible for up to one million babies being born with a low birth weight every year. Significant efforts have been invested into preventing the condition. Areas covered: Pub Med was searched using the broad terms 'malaria parasite placenta' to identify studies of interactions between parasite and host, 'prevention of placental malaria' to identify current strategies to prevent placental malaria, and 'placental malaria vaccine' to identify pre-clinical vaccine development. However, all papers from these searches were not systematically included. Expert commentary: The first phase I clinical trials of vaccines are well underway. Trials testing efficacy are more complicated to carry out as only women that are exposed to parasites during pregnancy will contribute to endpoint measurements, further it may require extensive follow-up to establish protection. Future second generation vaccines may overcome the inherent challenges in making an effective placental malaria vaccine.

AB - Introduction: Malaria during pregnancy is a massive health problem in endemic areas. Placental malaria infections caused by Plasmodium falciparum are responsible for up to one million babies being born with a low birth weight every year. Significant efforts have been invested into preventing the condition. Areas covered: Pub Med was searched using the broad terms 'malaria parasite placenta' to identify studies of interactions between parasite and host, 'prevention of placental malaria' to identify current strategies to prevent placental malaria, and 'placental malaria vaccine' to identify pre-clinical vaccine development. However, all papers from these searches were not systematically included. Expert commentary: The first phase I clinical trials of vaccines are well underway. Trials testing efficacy are more complicated to carry out as only women that are exposed to parasites during pregnancy will contribute to endpoint measurements, further it may require extensive follow-up to establish protection. Future second generation vaccines may overcome the inherent challenges in making an effective placental malaria vaccine.

U2 - 10.1080/14760584.2017.1322512

DO - 10.1080/14760584.2017.1322512

M3 - Journal article

C2 - 28434376

VL - 16

SP - 613

EP - 624

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 6

ER -

ID: 178245907